Voltar
Artigo Revisado por pares
BIBTEX RIS

Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trial

2010; Springer Science+Business Media; Volume: 67; Issue: 1 Linguagem: Inglês

10.1007/s00280-010-1483-x

ISSN

1432-0843

Autores

Binghe Xu, Zefei Jiang, Zhimin Shao, Jiayu Wang, Jifeng Feng, Shuping Song, Zhendong Chen, Kangsheng Gu, Shiying Yu, Yiping Zhang, Chuan Wang, Fengchun Zhang, Junlan Yang,

Tópico(s)

HER2/EGFR in Cancer Research

Referência(s)